Legal & General Group Plc - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$29,841
+25.1%
2,130
-7.6%
0.00%
Q2 2023$23,857
-72.3%
2,305
-76.6%
0.00%
Q1 2022$86,000
+218.5%
9,857
+253.4%
0.00%
Q4 2021$27,000
-42.6%
2,7890.0%0.00%
Q3 2021$47,000
+11.9%
2,7890.0%0.00%
Q2 2021$42,000
-22.2%
2,7890.0%0.00%
Q1 2021$54,000
-6.9%
2,789
-13.5%
0.00%
Q4 2020$58,000
-6.5%
3,2240.0%0.00%
Q3 2020$62,000
-41.0%
3,224
-19.9%
0.00%
Q2 2020$105,000
+43.8%
4,027
-1.3%
0.00%
Q1 2020$73,000
-56.0%
4,080
-18.0%
0.00%
Q4 2019$166,000
+66.0%
4,973
+17.6%
0.00%
Q3 2019$100,000
-28.6%
4,2270.0%0.00%
Q2 2019$140,000
+324.2%
4,227
+365.5%
0.00%
Q1 2019$33,000
+106.2%
908
+144.1%
0.00%
Q4 2018$16,000
-5.9%
3720.0%0.00%
Q3 2018$17,000
-5.6%
3720.0%0.00%
Q2 2018$18,0003720.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders